Karen Cui
- Oncology top 2%
- Cancer Research top 2%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Genetics top 10%
- Co-authors
- Talia GolanHedy L. KindlerEileen M. O’ReillyGiampaolo TortoraMichele ReniDaniel HochhauserHana AlgülDavid McGuinness
- Topics
- PARP inhibition in cancer therapy (21 papers)Pancreatic and Hepatic Oncology Research (11 papers)Advanced Breast Cancer Therapies (10 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Karen Cui
25 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Oncology 1.6k
- Cancer Research 820
- Molecular Biology 729
- Pulmonary and Respiratory Medicine 367
- Genetics 230
Countries citing papers authored by Karen Cui
This map shows the geographic impact of Karen Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Cui more than expected).
Fields of papers citing papers by Karen Cui
This network shows the impact of papers produced by Karen Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Cui. The network helps show where Karen Cui may publish in the future.
Co-authorship network of co-authors of Karen Cui
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Cui. A scholar is included among the top collaborators of Karen Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Cui. Karen Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | 4 | |
| 4 | 8 | |
| 5 | 5 | |
| 6 | 120 | |
| 7 | 26 | |
| 8 | 5 | |
| 9 | 1 | |
| 10 | 2 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancerbreakdown → | 1468 |
| 14 | 33 | |
| 15 | 3 | |
| 16 | 0 | |
| 17 | 10 | |
| 18 | 2 | |
| 19 | 1 | |
| 20 | Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors. | 158 |
About Karen Cui
Karen Cui is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 1.9k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (21 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Advanced Breast Cancer Therapies (10 papers). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (820 citations) and Pulmonary and Respiratory Medicine (367 citations). Karen Cui has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Talia Golan, Hedy L. Kindler, Eileen M. O’Reilly, Giampaolo Tortora, Michele Reni, Daniel Hochhauser, Hana Algül, David McGuinness, Eric Van Cutsem and Do‐Youn Oh. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.